Investors

We are committed to developing
the first and only FDA-approved
TAVR solution for severe AR

Our Global Investors

Latest News

View All
Press
JenaValve
March 16, 2026
JenaValve Announces FDA Premarket Approval of the Trilogy™ Transcatheter Heart Valve System
Read More
Press
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
November 24, 2025
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
Read More
Press
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
November 10, 2025
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
Read More
Close Download
The JenaValve TrilogyTM Heart Valve System Billing Guide contains appropriate coding (e.g. CPT, ICD-10, and HCPCS), coverage, and payment for procedures performed with the JenaValve TrilogyTM Heart Valve System. For additional information, please contact us at reimbursement.usa@jenavalve.com.